// App-Quantinova.ai

297.0 : Symptom burden at the end of life for neuroendocrine tumors: A population-based analysis of patient-reported outcomes.

Researchers

Presenter

  • Julie I. Hallet

Principal Investigators

  • Laura Davis

  • Alyson L. Mahar

  • Calvin Law

  • Lev Bubis

  • Elie Isenberg-Grzeda

  • Simron Singh

  • Sten Myrehaug

  • Haoyu Zhao

  • Kaitlyn Beyfuss

  • Lesley Moody

  • Natalie G. Coburn

Medical Centers

  • Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada

  • Sunnybrook Research Institute, Toronto, ON, Canada

  • Faculty of Medicine, University of Manitoba, Winnipeg, MB, Canada

  • Department of Surgery, University of Toronto, Toronto, ON, Canada

  • Sunnybrook Odette Cancer Centre, Toronto, ON, Canada

  • Sunnybrook Health Sciences Centre, Toronto, ON, Canada

  • OICR, Toronto, ON, Canada

  • Cancer Care Ontario, Toronto, ON, Canada

  • Sunnybrook Health Sciences Centre and Odette Cancer Centre, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Neuroendocrine tumors

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved